Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics | $8.68 | -$5.41 | -38.40% | 20.1K | $127M | $6.53$29.98 |
| ICLR | Icon Public | $82.97 | -$50.17 | -37.68% | 824.3K | $10B | $66.58$211.00 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $8.95 | -$5.12 | -36.39% | 13.2M | - | $6.74$52.54 |
| OBAI | Tg-17 | $4.66 | -$1.99 | -29.93% | 281.4K | $68M | $3.97$38.50 |
| RUBI | Rubico | $2.97 | -$1.09 | -26.79% | 353.3K | - | $2.87$1,565.46 |
| RXO | RXO | $12.31 | -$4.02 | -24.62% | 793.4K | $2.7B | $10.43$22.17 |
| CSCL | Direxion Shares ETF Trust - Direxion Daily Csco Bull 2x ETF | $28.15 | -$8.73 | -23.67% | 82.9K | - | $23.17$38.90 |
| QDEL | QuidelOrtho | $22.22 | -$6.58 | -22.85% | 146.5K | $2.0B | $19.50$43.92 |
| LMNX | Tidal Trust II - Defiance Daily Target 2x Long Lmnd ETF | $19.11 | -$5.53 | -22.44% | 54.9K | - | $15.95$55.00 |
| NRGV | Energy Vault | $3.21 | -$0.86 | -21.06% | 619K | $681M | $0.60$6.35 |
| ASTI | Ascent Solar Technologies | $7.13 | -$1.90 | -21.01% | 5.6M | $43M | $1.10$9.87 |
| GITS | Global Interactive Technologies | $2.13 | -$0.54 | -20.23% | 86K | $9.8M | $0.66$7.09 |
| DLLL | GraniteShares ETF Trust - GraniteShares 2x Long Dell Daily ETF | $17.65 | -$4.26 | -19.46% | 138.3K | - | $7.71$42.72 |
| NCI | Neo-Concept International Group | $2.13 | -$0.51 | -19.32% | 7.7M | $11M | $0.72$3.41 |
| MICC | Magnum Ice Cream | $16.06 | -$3.81 | -19.18% | 3.5M | $12B | $14.45$19.93 |
| UPC | Universe Pharmaceuticals Inc | $2.94 | -$0.68 | -18.79% | 49K | $2.0M | $2.51$13.95 |
| OM | Outset Medical | $3.69 | -$0.85 | -18.72% | 26.5K | $82M | $3.10$21.98 |
| XYZG | Themes ETF Trust - Leverage Shares 2x Long Xyz Daily ETF | $7.85 | -$1.78 | -18.47% | 65K | - | $7.66$28.60 |
| UTZ | Utz Brands | $9.10 | -$2.03 | -18.24% | 89.6K | $974M | $8.96$14.67 |
| BEG | Themes ETF Trust - Leverage Shares 2x Long Be Daily ETF | $31.42 | -$6.95 | -18.11% | 134.8K | - | $10.89$50.61 |
| MB | MasterBeef Group | $4.29 | -$0.93 | -17.82% | 2.5K | $90M | $2.73$16.40 |
| WSHP | WeShop | $38.74 | -$8.26 | -17.57% | 18.7K | $1.1B | $20.02$250.00 |
| LSTR | Landstar System | $134.47 | -$28.28 | -17.38% | 1.8M | $5.6B | $117.74$165.25 |
| RDIB | Reading International | $12.11 | -$1.99 | -14.11% | 5.8K | $320M | $5.81$17.40 |
Related Articles
Featured Article
A Motley Fool Potluck of Financial News and Insight
Motley Fool Staff|Dec 3, 2024
It's Motley Fool Money's annual Thanksgiving financial meal. We're serving up humble pie, talking about the topics we're skipping this year at the dinner table, and answering questions you've sent our way.
This Could Be the Best Growth Stock Under $20 on the Market Right Now
Keith Speights|Apr 23, 2023
Home is where the big money is for this up-and-coming healthcare company.
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
James Halley|Mar 25, 2023
These companies strive to bring down the cost of developing new therapies.
These 2 Nasdaq Stocks Got No Valentine's Day Love
Dan Caplinger|Feb 14, 2023
Quarterly financial performance left something to be desired from both of these companies.
Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000
Jason Hall and Jeff Santoro|Dec 23, 2022
Little-known Boston Omaha is a quiet compounder, while Outset Medical's dialysis treatment could change millions of lives.
2 Big Stock Winners From a Horrible Day on Wall Street
Dan Caplinger|Nov 9, 2022
If you like gains of 15% to 30%, these stocks are for you.
Here's Why This New Spinoff Stock Looks Like It Could Be a Market-Beater
Jeremy Bowman|Nov 8, 2022
Truck brokerage RXO looks like a winner.
Outset Medical Stock Is Soaring: Here's Why Even Bigger Gains Could Be Ahead
Keith Speights|Aug 2, 2022
A major FDA decision clears the way for Outset to again go after a huge opportunity.
Outset Medical Plunges on Shipment Hold: Buy the Stock on the Sell-Off?
Keith Speights|Jun 14, 2022
The temporary issue could present a great buying opportunity for long-term investors.
